A full pipeline is not the same as a healthy one. Revenue leaders know this intellectually, but under pressure to hit quarterly targets, the instinct is normally the same: add more activity, generate more leads, and trust that volume will solve the problem. Eric Maida, co-founder at MT Growth Partners, has spent his career working with founders, CEOs, and revenue leaders to build predictable, scalable go-to-market (GTM) motions. He believes the issue is rarely at the top of the funnel. It is almost always buried inside it. “Pipeline problems almost always come from one or two broken stages in the funnel,” Maida says. “Most teams immediately think they need more leads, but that’s usually the wrong answer.” The path to real pipeline health runs through three fundamentals that compound over time: stage conversion, deal velocity, and deal quality.
1. Stage Conversion Reveals Where Pipeline Is Actually Breaking
The first step in diagnosing pipeline health is one most revenue teams skip in favor of aggregate metrics. Rather than looking at overall conversion rates, Maida directs teams to examine stage-to-stage conversion over the previous 30 to 60 days, specifically looking for where the sharpest drop-offs occur and where rates have recently shifted. The exercise is deliberately precise. If discovery-to-demo conversion drops from 40% to 20%, that number is telling a specific story. “That’s not a volume problem,” Maida says. “It’s usually a targeting, qualification, or messaging issue.” Chasing it with more top-of-funnel activity makes the underlying problem harder to see, not easier to fix.
The structural fix is exit criteria, and Maida is clear that activity-based criteria do not qualify. Outcome-based criteria do. “If a rep cannot explain why a deal had the right to move forward, it probably shouldn’t have.” Building pipeline discipline at the executive level starts here: defining what a deal must demonstrate to advance, not simply what a rep must do to progress it. When conversion metrics are grounded in outcomes rather than actions, the data stops being decorative and starts being diagnostic.
2. Slow Deals Don’t Just Stall, They Distort Reality
A pipeline can look full on paper and still be deeply unhealthy. Deal velocity, how long opportunities sit in each stage and how long it takes to close once a deal is real, is the metric that exposes the difference between an active pipeline and a pipeline that is simply aging on the board. Maida has identified the same velocity killer appearing repeatedly, and that is the absence of a clearly defined next step. “If there is no next meeting on the calendar, it’s not a deal,” he says. “It’s a maybe.” That distinction matters enormously when GTM leaders are trying to turn pipeline insight into revenue confidence. A pipeline full of maybes does not produce predictable growth; it produces forecast surprises.
The fix is straightforward but requires discipline to enforce. Every stage transition should require a documented next step; who needs to be involved, what decision is being made, and when it will happen. “Velocity improves when expectations are mutual instead of implied,” Maida says. When those three elements are present, deals move. When they are absent, deals stall and stalled deals distort every forecast built around them.
3. Deal Quality Beats Deal Volume Every Time
Inflating pipeline to create the appearance of coverage is one of the most common and costly habits in enterprise sales. A smaller pipeline with high-quality deals will outperform a bloated one every time. Deal quality, in his framework, comes down to three elements:
- The problem must be real and tied to a measurable business impact.
- Access must extend beyond a single champion to actual decision-makers.
- And the path to a decision must be clearly understood by both sides.
“If any of those are unclear, the deal is fragile,” Maida says. The practical application is a simple, informal scoring model, evaluating each deal on problem strength, power, and path forward, followed by coaching reps to improve deal quality rather than push close dates. “When deal quality goes up, forecasts get cleaner, and surprises disappear altogether.”
For revenue leaders building toward predictable, scalable growth, that outcome is worth more than any volume metric. Pipeline health is not built by working harder or moving faster. It is built by focusing on the fundamentals that compound. “Pick one stage, one stuck deal, or one low-quality opportunity this week,” Maida says, “and fix that first. That’s how real pipeline health gets built.”
Connect with Eric Maida on LinkedIn for more insights.
